Prostate biopsy findings in the extended biopsy era for PSA lower than 4ng/ml

被引:0
|
作者
Leite, Katia R. M.
Srougi, Miguel
Dall'Oglio, Marcos F.
Antunes, Alberto A.
Cury, Jose
Sanudo, Adriana
Camara-Lopes, Luiz Heraldo A.
机构
来源
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词
D O I
10.1016/S0022-5347(18)31942-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:583 / 583
页数:1
相关论文
共 50 条
  • [41] Lowering the PSA Threshold for Prostate Biopsy from 4 to 2.5 ng/ml: Influence on Cancer Characteristics and Number of Men Needed to Biopt
    Muentener, Michael
    Kunz, Urs
    Eichler, Klaus
    Puhan, Milo
    Schmid, Daniel M.
    Sulser, Tullio
    Strebel, Raeto T.
    [J]. UROLOGIA INTERNATIONALIS, 2010, 84 (02) : 141 - 146
  • [42] Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4-10 ng/mL
    Zhou, Yongqiang
    Li, Yun
    Li, Xiangnan
    Jiang, Minjun
    [J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [43] Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL?
    Busato, W. F. S.
    Almeida, G. L.
    Geraldo, Jamylle
    Busato, F. S.
    [J]. INTERNATIONAL BRAZ J UROL, 2015, 41 (02): : 329 - 336
  • [44] PSA, PSA density and transition zone density in the era of extended biopsy schemes
    Elliott, Christopher S.
    Shinghal, Rajesh
    Presti, Joseph C.
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 605 - 605
  • [45] Comparison of contrast-enhanced color doppler targeted biopsy and systematic biopsy: Impact on prostate cancer detection in men with PSA levels between 4 and 10 ng/ml
    Pelzer, A
    Horninger, W
    Lunacek, A
    Akkad, T
    Koppelstaetter, F
    Bartsch, G
    Frauscher, F
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 479 - 480
  • [46] Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?
    Oh, Jong Jin
    Jeong, Seong Jin
    Jeong, Chang Wook
    Byun, Seok-Soo
    Hong, Sung Kyu
    Choe, Gheeyoung
    Lee, Sang Eun
    [J]. PROSTATE, 2013, 73 (01): : 42 - 47
  • [47] Cancer diagnosis with prostate specific antigen greater than 10 ng/ml and negative peripheral zone prostate biopsy
    Fowler, JE
    Condon, MA
    Terrell, FL
    [J]. JOURNAL OF UROLOGY, 1996, 156 (04): : 1370 - 1374
  • [48] Accuracy of percent free PSA in PSA ranges lower than 2.5ng/ml
    Haese, A.
    Walz, J.
    Gallina, A.
    Steuber, T.
    Briganti, A.
    Chun, F.
    Eichelberg, C.
    Zanni, G.
    Rigatti, P.
    Montorsi, F.
    Graefen, M.
    Huland, H.
    Karakiewicz, P.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 223 - 223
  • [49] Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL
    Kawamura, Koji
    Suzuki, Hiroyoshi
    Kamiya, Naoto
    Imamoto, Takashi
    Yano, Masashi
    Miura, Junichiro
    Shimbo, Masaki
    Suzuki, Noriyuki
    Nakatsu, Hiroomi
    Ichikawa, Tomohiko
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (07) : 598 - 603
  • [50] Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA < 10 ng/ml
    Andras, Iulia
    Crisan, Nicolae
    Vesa, Stefan
    Rahota, Razvan
    Romanciuc, Florina
    Lazar, Andrei
    Socaciu, Carmen
    Matei, Deliu-Victor
    de Cobelli, Ottavio
    Bocsan, Ioan-Stelian
    Coman, Radu-Tudor
    [J]. FUTURE ONCOLOGY, 2017, 13 (20) : 1793 - 1800